agilon health (AGL) Fundamental Analysis: Revenue, Earnings & Valuation

8.09 / 10

Outperform

Fundamentally, the stock rates Outperform with an 8.1/10 quality score. Positive drivers include rising operating cash flow and EPS growth, while revenue‑to‑market and inventory turnover lag, yielding a generally favorable but not flawless outlook.

Analysis Checks(4/10)

Revenue-MV

Value3.46

Score1/3

Weight9.42%

1M Return2.00%

Net cash flow from operating activities per share (YoY growth rate %)

Value-81.94

Score2/3

Weight18.15%

1M Return3.60%

Inventory turnover ratio

Value106.57

Score1/3

Weight8.27%

1M Return1.74%

Net income-Revenue

Value-0.04

Score0/3

Weight-9.96%

1M Return-2.25%

Basic earnings per share (YoY growth rate %)

Value-50.79

Score3/3

Weight35.08%

1M Return6.64%

Total profit (YoY growth rate %)

Value-62.40

Score0/3

Weight-9.77%

1M Return-2.61%

Net cash flow from operating activities (YoY growth rate %)

Value-83.05

Score2/3

Weight19.38%

1M Return3.84%

Cash-UP

Value-0.16

Score1/3

Weight3.67%

1M Return0.84%

Diluted earnings per share (YoY growth rate %)

Value-50.79

Score3/3

Weight36.06%

1M Return6.86%

Cash-MV

Value0.03

Score0/3

Weight-10.29%

1M Return-2.55%

Is AGL fundamentally strong?

AGL scores 8.09/10 on fundamentals and holds a Discounted valuation at present. Backed by its -130.95% ROE, -6.60% net margin, -0.46 P/E ratio, 1.43 P/B ratio, and -50.79% earnings growth, these metrics solidify its Outperform investment rating.